Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Phase Study for Primary and Secondary Prevention of Diabetic Nephropathy by Combined ACE Inhibition and Calcium Channel Blockade (BENEDICT)

NCT00235014 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00235014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Phase Study for Primary and Secondary Prevention of Diabetic Nephropathy by Combined ACE Inhibition and Calcium Channel Blockade (BENEDICT)
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
March 31, 1997
Completion date
Not reported
Enrollment
1,204 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension